Research map: State of the Art: Personalized Antiplatelet Therapy by Genotype and Platelet Function Testing

Back to the article

Papers in this map

  1. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation · Authors Task Force Members · 2011 · 3097 citations · Cited by this paper
  2. The Sequence of Post‐Dilation Matters: Proximal Optimization Technique (POT) Reduces Longitudinal Stent Deformation Assessed by Intravascular Ultrasound · 2026 · Related
  3. 2024 ESC Guidelines for the management of chronic coronary syndromes · Christiaan J. Vrints · 2024 · 2786 citations · Cited by this paper
  4. Balloon Rupture During Myval TAVI: A Rare Complication and Successful Bailout Strategy · 2026 · Related
  5. Cytochrome P-450 Polymorphisms and Response to Clopidogrel · Jessica L. Mega · 2008 · 2502 citations · Cited by this paper
  6. The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry · 2023 · Related
  7. Clopidogrel for Coronary Stenting · Paul Alfred Gurbel · 2003 · 1546 citations · Cited by this paper
  8. Comparison of Immediate Versus Staged Complete Revascularization in Patients With Index PCI Coronary Complications: A Study on Clinical Outcomes and Predictors of Complications · 2026 · Related
  9. Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy · Alan R. Shuldiner · 2009 · 1513 citations · Cited by this paper
  10. A Randomized Trial Comparing Potato Poultice Compress Versus Traditional Medicated Compress for Forearm Swelling After Trans‐Radial Percutaneous Coronary Intervention · 2026 · Related
  11. Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention · Matthew J. Price · 2011 · 1309 citations · Cited by this paper
  12. The Hidden Burden of Iatrogenic Atrial Shunting in Severe Tricuspid Regurgitation: A Case Report · 2026 · Related
  13. Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease · Paul Alfred Gurbel · 2009 · 1162 citations · Cited by this paper
  14. Impact of Failure Mode and Effects Analysis‐Oriented Multidisciplinary Collaborative Nursing Model on Bleeding Prevention and Prognosis in Patients Undergoing Transradial Artery Coronary Angiography: A Randomized Controlled Trial · 2026 · Related
  15. Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate · Laurent Bonello · 2010 · 1153 citations · Cited by this paper
  16. Balancing Circulatory Support and Ventricular Unloading in Post‐Infarction Ventricular Septal Perforation: A Computational Analysis of ECPELLA Support Configurations · 2026 · Related
  17. Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI · Jessica L. Mega · 2010 · 1141 citations · Cited by this paper
  18. First Report of Kounis Syndrome after Zopiclone—When Morpheus Misfires · 2026 · Related
  19. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update · Stuart A. Scott · 2013 · 975 citations · Cited by this paper
  20. Stent Underexpansion Prediction Is Improved by Intravascular Ultrasound‐Based Distance‐Averaged Calcium Angles · 2026 · Related
  21. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding · Udaya S. Tantry · 2013 · 909 citations · Cited by this paper
  22. Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting · Jean‐Philippe Collet · 2012 · 885 citations · Cited by this paper
  23. Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention · Stephen D. Wiviott · 2007 · 883 citations · Cited by this paper
  24. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study · Gregg W. Stone · 2013 · 864 citations · Cited by this paper
  25. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial · Lars C. Wallentin · 2010 · 802 citations · Cited by this paper
  26. Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel · Jessica L. Mega · 2009 · 654 citations · Cited by this paper
  27. A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI · Daniel M.F. Claassens · 2019 · 654 citations · Cited by this paper
  28. Platelet Reactivity in Patients and Recurrent Events Post-Stenting · Paul Alfred Gurbel · 2005 · 649 citations · Cited by this paper
  29. A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents · Dietmar Trenk · 2012 · 624 citations · Cited by this paper
  30. Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial · Dirk Sibbing · 2017 · 612 citations · Cited by this paper
  31. Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis · Paul Alfred Gurbel · 2005 · 537 citations · Cited by this paper
  32. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update · Craig R. Lee · 2022 · 514 citations · Cited by this paper
  33. Platelet Function Monitoring in Patients With Coronary Artery Disease · Paul Alfred Gurbel · 2007 · 479 citations · Cited by this paper
  34. Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies · Paul Alfred Gurbel · 2010 · 447 citations · Cited by this paper
  35. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention · Naveen L. Pereira · 2020 · 422 citations · Cited by this paper
  36. Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA · Yongjun Wang · 2021 · 407 citations · Cited by this paper
  37. Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention · Kevin P. Bliden · 2007 · 398 citations · Cited by this paper
  38. Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration · Jean‐Sébastien Hulot · 2010 · 383 citations · Cited by this paper
  39. Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial · Guillaume Cayla · 2016 · 379 citations · Cited by this paper

Source: OpenAlex (CC0)